TY  - GEN
AU  - Berthon,Céline
AU  - Raffoux,Emmanuel
AU  - Thomas,Xavier
AU  - Vey,Norbert
AU  - Gomez-Roca,Carlos
AU  - Yee,Karen
AU  - Taussig,David Christopher
AU  - Rezai,Keyvan
AU  - Roumier,Christophe
AU  - Herait,Patrice
AU  - Kahatt,Carmen
AU  - Quesnel,Bruno
AU  - Michallet,Mauricette
AU  - Recher,Christian
AU  - Lokiec,François
AU  - Preudhomme,Claude
AU  - Dombret,Hervé
TI  - Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
SN  - 2352-3026
PY  - 2017///1018
KW  - Acetanilides
KW  - administration & dosage
KW  - Aged
KW  - Antineoplastic Agents
KW  - Canada
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Female
KW  - France
KW  - Heterocyclic Compounds, 3-Ring
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Treatment Outcome
KW  - United Kingdom
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/S2352-3026(15)00247-1
ER  -